Supreme Court will not hear J&J’s appeal over ruling in favor of women who said they developed ovarian cancer from using talc products
WEDNESDAY, June 2, 2021 (HealthDay News) — The U.S. Supreme Court said Tuesday that it will not hear Johnson & Johnson’s appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company’s talc products.
The nation’s top court did not say why it rejected Johnson & Johnson’s appeal, the Associated Press reported.
A state court in Missouri initially awarded $4.7 billion to 22 women, but a state appeals court cut that to $2 billion and eliminated two of the plaintiffs.
Johnson & Johnson claimed it was not treated fairly because it faced one trial involving 22 plaintiffs from 12 states and different backgrounds, the AP reported.
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
Residential Context Has Larger Impact on Ovarian Cancer Survival in Black Women 
Family History Drives Cancer Risk in BRCA Test Groups .jpg)
40 Percent Diagnosed With Ovarian Cancer After Emergency Admission 
ED Visits, Hospitalizations for Alcohol, Cannabis Vary by Age 
Rates of Pediatric E-Bicycle, E-Scooter Injuries Increasing 
Withdrawal From Medetomidine Increasingly Seen in ICUs 
Multicomponent Interventions Offer Little Impact on Fall Risk 
